Yuri Nikolsky

Yuri Nikolsky is an accomplished executive and entrepreneur with a strong background in life sciences spanning over 20 years. His expertise includes research management, product development, consulting, sales, marketing, M&A, and company evaluations. He is best known for his leadership role at GeneGo, a pioneer in systems biology and precision medicine. Following the acquisition of GeneGo by Thomson Reuters, Yuri built and led a top consulting team specializing in personalized and translational medicine, patient stratification, drug repositioning, and big data management for leading pharmaceutical companies. He then served as the Chief Scientific Officer at Skolkovo Foundation, where he assessed numerous biotech and agrotech startups and collaborated with VC funds and global pharma firms.